🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, w...
Status
Completed
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2009-12
Trial ID
NCT00949247
Treatments Being Tested
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
The investigators research aim to explores the optimal comprehensive treatm...
Status
Unknown
Location
Cancer Hospital & Institute Chinese Academy of Medical Sciences (CAMS)
Start Date
2014-10
Trial ID
NCT02934828
Treatments Being Tested
Both TCH (docetaxel/carboplatin/trastuzumab) and EC followed by TH(epirubic...
Status
Completed
Location
Guangdong General Hospital
Start Date
2016-09-01
Trial ID
NCT03140553
The primary objective of this study is to determine the efficacy of metform...
Status
Unknown
Location
The University of Kansas Cancer Center, West Clinic
Start Date
2017-08-15
Trial ID
NCT03238495
Treatments Being Tested
This is a pragmatic, randomized, controlled, equivalency trial. This 12-mon...
Status
Completed
Location
University of Southern California
Start Date
2019-08-27
Trial ID
NCT03981926
Treatments Being Tested
The main clinical goal of NAC is to down-stage the primary tumor for BCS,ye...
Status
Unknown
Location
Shandong Cancer Hospital
Start Date
2008-08
Trial ID
NCT01917578
The primary objective: -To assess the efficacy of TCH and TCHL in neo-adju...
Status
Completed
Location
St James's Hospital
Start Date
2010-10
Trial ID
NCT01485926
Treatments Being Tested
The goal of this clinical trial is to learn if a brief parent educational v...
Status
Enrolling By Invitation
Location
Texas Children's Hospital
Start Date
2026-04-14
Trial ID
NCT07566546
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Terminated
Location
Central Jersey Oncology Center, PA - East Brunswick
Start Date
2005-04
Trial ID
NCT00118053
Treatments Being Tested